Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
10/2002
10/10/2002WO2002079257A1 Novel compound for treatment of allergy and asthma
10/10/2002WO2002079256A1 Antibody and utilization thereof
10/10/2002WO2002079255A1 RECOMBINANT ANTIBODIES COEXPRESSED WITH GnTIII
10/10/2002WO2002079254A1 Human monoclonal antibodies against capsular polysaccharides of streptococcus pneumoniae
10/10/2002WO2002079249A2 New polynucleotides and polypeptides of the ifn$g(a)-21 gene
10/10/2002WO2002079248A2 Mammalian alpha-helical protein-53
10/10/2002WO2002079243A2 Gonococcal proteins and nucleic acids
10/10/2002WO2002079232A2 Reducing the immunogenicity of fusion proteins
10/10/2002WO2002079230A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002WO2002079217A1 A hepatitis b virus surface antigen mutant and methods of detection thereof
10/10/2002WO2002078766A2 Combination therapy
10/10/2002WO2002078743A1 Compositions and methods for reducing tranfusion reactions
10/10/2002WO2002078742A2 Methods and compositions for treatment of immune dysfunction disorders
10/10/2002WO2002078741A2 Methods and compositions for modulating the immune system of animals
10/10/2002WO2002078739A1 Drugs containing genetically modified antibody against ganglioside gd3
10/10/2002WO2002078738A1 Blood rheology improving agents
10/10/2002WO2002078731A1 Module of pd-1 interactions with its ligands
10/10/2002WO2002078729A1 Compositions and methods for diagnosing or treating psoriasis
10/10/2002WO2002078640A2 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/10/2002WO2002078638A2 Morpholino imaging and therapy
10/10/2002WO2002078630A2 Tub 3'-variant
10/10/2002WO2002078613A2 Immunoglobulin construct containing anti-mucin variable domain sequences for eliciting an anti-idiotype anti-tumor response
10/10/2002WO2002078612A2 Thrombopoietin (tpo) synthebody for stimulation of platelet production
10/10/2002WO2002078609A2 Immunoglobulin construct containing tumor specific p53bp2 sequences for eliciting an anti-tumor response
10/10/2002WO2002078608A2 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent
10/10/2002WO2002078598A2 Peptides and antibodies to muc 1 proteins
10/10/2002WO2002078526A2 Cancer-testis antigens
10/10/2002WO2002078520A2 IL-1ss INHIBITION FOR MYELOMA AND RELATED DISORDERS
10/10/2002WO2002070552A8 POLYPEPTIDE FROM A HDM2 PROTEIN SPECIFIC MURINE Α/β T-CELL RECEPTORS, NUCLEIC ACIDS CODING FOR THE ABOVE AND USE THEREOF
10/10/2002WO2002059149A3 Pro-apoptotic proteins and dna molecules encoding them
10/10/2002WO2002034895A3 Novel aggrecanase molecules
10/10/2002WO2002033043A3 Method and marker for the isolation of human multipotent hematopoietic stem cells
10/10/2002WO2002016419A3 Progression suppressed gene 13 (psgen 13) and uses thereof
10/10/2002WO2002012481A3 Enhancement of industrial production by increasing substrate transport
10/10/2002WO2002004612A3 Drug metabolizing enzymes
10/10/2002WO2001098353A3 Secreted proteins
10/10/2002WO2001093908A9 Immunotherapeutic method to prevent islet cell rejection
10/10/2002WO2001077174A3 Human transporters and ion channels
10/10/2002WO2001053324A8 Novel haptotactic peptides
10/10/2002US20020147326 Fusion protein for use in the treatment of autoimmune diseases tissue grafting defect
10/10/2002US20020147325 Antibodies to receptor protein kinases
10/10/2002US20020147324 RPS gene family, primers, probes, and detection methods
10/10/2002US20020147322 Nucleotide sequences coding polypeptides for use in the prevention, diagnosis and treatment of cancer
10/10/2002US20020147314 Nucleotide sequences coding polypeptide for use in the treatment of inflammatory bowel disease
10/10/2002US20020147313 Isolated bovine IgG heavy chain protein and its use as an antimicrobial
10/10/2002US20020147312 Hybrid antibody for use in the treatment, diagnosis and prevention of cancer and immunological disorders
10/10/2002US20020147311 Fusion protein for use in the treatment of tumors
10/10/2002US20020147310 Nucleotide sequences coding polypeptides for use in the treatment of inflammatory and autoimmune diseases
10/10/2002US20020147305 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002US20020147173 Methods of treatment using NBS-1, antibodies and proteins thereto, and uses of the antibodies
10/10/2002US20020147162 Methods of modulating angiogenesis by regulating the expression of pituitary tumor transforming gene (PTTG)
10/10/2002US20020147161 Novel antisense inhibition of rad51
10/10/2002US20020147143 Diagnosis, therapy; anticancer agents
10/10/2002US20020146846 Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment
10/10/2002US20020146827 Expression vector for use as genetic engineering tool in the amplification of prefeerential products
10/10/2002US20020146824 Novel transcription enhancer element and transcription factor and methods of use thereof
10/10/2002US20020146819 Human TSLP DNA and polypeptides
10/10/2002US20020146806 Nucleotide sequences coding polypeptides for use in the treatment of rheumatic and autoimmune diseases
10/10/2002US20020146805 DNA encoding the human serine protease T
10/10/2002US20020146804 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of ischemic injury, nervous system and inflammatory disorders
10/10/2002US20020146791 Corpuscles of stannius protein, stanniocalcin
10/10/2002US20020146774 Smad2 phosphorylation and interaction with Smad4
10/10/2002US20020146773 ''Signalin'' family of TGFbeta signal transduction proteins, and uses related thereto
10/10/2002US20020146772 Nucleotide equences coding enzymatic polypeptide for use in the treatment of blood disorders and thrombosis
10/10/2002US20020146768 Apoliprotein for use in treatment of stroke, heart defects, reperfusion injuries, viral, nervous system, vision and blood disorders
10/10/2002US20020146759 Stress proteins and peptides and methods of use thereof
10/10/2002US20020146753 Immunopolypeptide for use in the treatment, prevention and diagnosis of autoimmune diseases
10/10/2002US20020146750 Mucin for use in the diagnosiss and treatment of cancer
10/10/2002US20020146749 Diagnosis and treatment of neuroectodermal tumors
10/10/2002US20020146748 Immunological detection of neosporosis using a recombinant antigen
10/10/2002US20020146712 Tumor suppressor
10/10/2002US20020146709 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/10/2002US20020146707 Cardiotrophin-1 compositions and methods for the treatment of tumor
10/10/2002US20020146702 Nucleic acid molecule associated with prostate cancer and melanoma immunodetection and immunotherapy
10/10/2002US20020146695 Method for detection of the presence or absence of methylthioadenosine phosphorylase (MTAse) in a cell sample by detection of the presence or absence of MTAse encoding nucleic acid in the cell sample
10/10/2002US20020146687 Detecting cancer in humans; obtain cells, incubate with cadherins, monitor binding
10/10/2002US20020146504 Ternary biomolecule/polymer/surface-based immobilization systems
10/10/2002US20020146423 Protective helicobacter antigens
10/10/2002US20020146422 For therapy of asthma; allergies to pollen, fur, and/or house dust; various food allergies; and various forms of eczema
10/10/2002US20020146421 Diagnosis and treatment of malignant neoplasms
10/10/2002US20020146420 Protein tyrosine kinase agonist antibodies
10/10/2002US20020146419 Methods of treating ankylosis with chimeric anti-TNF antibodies
10/10/2002US20020146417 Administering function blocking antibody or a fragment antibody, capable of binding an epitope of VLA-1 to provide a decrease in arthritic score of about 65% or greater when compared to control antibody treated subject
10/10/2002US20020146416 Human trk receptors and neurotrophic factor inhibitors
10/10/2002US20020146415 Methods for inhibiting HIV-1 infection
10/10/2002US20020146411 Anticoagulant agents useful in treatment of thrombosis
10/10/2002US20020146410 Monoclonal antibodies and their use
10/10/2002US20020146408 Human haemopoietic maturation factor
10/10/2002US20020146391 For diagnosis and therapy of susceptibility to atopic allergy, asthma
10/10/2002US20020146389 For inducing apoptosis in mammalian cancer cells; stimulating a proinflammatory response in mammalian cells
10/10/2002US20020146388 Cytokine immunoconjugates
10/10/2002DE10117381A1 Herstellung polyklonaler, monospezifischer Antikörper gegen die uPAR-Varianten del4, del5 und del4+5 sowie deren Verwendung für diagnostische und therapeutische Zwecke Production of polyclonal, monospecific antibodies to uPAR variants del4, del5 and del4 + 5 and their use for diagnostic and therapeutic purposes
10/10/2002DE10114063A1 New DNA sequences from potato, useful for producing plants with altered properties, e.g. tolerance of flooding, also related proteins, antibodies and inhibitory sequences
10/10/2002CA2455915A1 Methods and compositions for using mhc class ii invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
10/10/2002CA2443138A1 Anti-muc-1 single chain antibodies for tumor targeting
10/10/2002CA2442847A1 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof
10/10/2002CA2442801A1 Recombinant antibodies coexpressed with gntiii
10/10/2002CA2442775A1 New polynucleotides and polypeptides of the ifn alpha-21 gene
10/10/2002CA2442684A1 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
10/10/2002CA2442619A1 Cancer-testis antigens
1 ... 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 ... 1494